You are here

  • Home
  • Archive
  • Volume 63, Issue 4
  • Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment

Citation Tools

Article menu
Download PDFPDF
Inflammatory bowel disease
Original article
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Tillack C, Ehmann LM, Friedrich M, et al
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
Gut 2014;63:567-577.